Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| NIMH, 1 R34 MH071201-01A1 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institute of Mental Health (NIMH) | NIH |
| Summa Health System | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The primary aim of this project is to examine the efficacy of prolonged exposure (PE) therapy at reducing HIV-related PTSD symptoms, increasing adherence to antiretroviral medication regimens, and increasing health-related quality of life (QOL) in HIV+ patients.
HIV+ patients will be randomized to receive either PE therapy (up to 18 possible sessions) or weekly symptom monitoring (described below) and will complete measures of PTSD, adherence, and QOL pre- and post-intervention and at 3- and 6-month follow-up assessments. Secondary analyses will examine the impact of the intervention on disorders commonly comorbid with PTSD (i.e., anxiety, mood, and substance abuse/dependence disorders).
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 | Experimental | Prolonged Exposure Therapy. |
|
| 2 | No Intervention | Weekly monitoring/Waitlist Control Group. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Prolonged Exposure Therapy | Behavioral | Participants will meet with a therapist twice a week for 5 weeks to complete the therapy. If the therapist and participant feel more sessions are needed, an additional 8 sessions will be provided. |
| Measure | Description | Time Frame |
|---|---|---|
| PTSD symptoms | pre- & post-intervention, 3-month post, & 6-month post |
| Measure | Description | Time Frame |
|---|---|---|
| Adherence to HIV medications | pre- & post-intervention, 3-month post, & 6-month post | |
| Health-related Quality of Life | pre- & post-intervention, 3-month post, & 6-month post |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Douglas L Delahanty, PhD | Kent State University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Violet's Cupboard | Akron | Ohio | 44310 | United States | ||
| AIDS Taskforce of Greater Cleveland |
| Type | Date | Date Unknown |
|---|---|---|
| Release | Apr 9, 2014 | |
| Reset | May 8, 2014 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Apr 9, 2014 | May 8, 2014 |
| ID | Term |
|---|---|
| D013313 | Stress Disorders, Post-Traumatic |
| D015658 | HIV Infections |
| ID | Term |
|---|---|
| D040921 | Stress Disorders, Traumatic |
| D000068099 | Trauma and Stressor Related Disorders |
| D001523 | Mental Disorders |
| D000086982 | Blood-Borne Infections |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Cleveland |
| Ohio |
| 44115 |
| United States |
| D003141 | Communicable Diseases |
| D007239 | Infections |
| D015229 | Sexually Transmitted Diseases, Viral |
| D012749 | Sexually Transmitted Diseases |
| D016180 | Lentivirus Infections |
| D012192 | Retroviridae Infections |
| D012327 | RNA Virus Infections |
| D014777 | Virus Diseases |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D007153 | Immunologic Deficiency Syndromes |
| D007154 | Immune System Diseases |